← Open Payments lookup

LILIAN SERPAS: Open Payments

NPI 1396375390 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,516 in 148 payments from 17 companies in 2025. Trend: 2023 $1,654 · 2024 $3,486 · 2025 $4,516

Food & beverage: $4,246Education: $260Travel & lodging: $10
CompanyPaymentsAmount
ABBVIE INC.21$880
UCB, Inc.38$848
Novartis Pharmaceuticals Corporation17$408
Galderma Laboratories, L.P.12$398
Incyte Corporation11$344
Arcutis Biotherapeutics, Inc.14$252
Organon LLC11$238
GENZYME CORPORATION7$195
Botanix SB Inc2$174
LEO Pharma Inc.3$167

Products named: Bimzelx, SKYRIZI, DUPIXENT, NEMLUVIO, OPZELURA, Zoryve, VTAMA, RINVOQ.

Industry payments across CA — which companies pay providers there.